Your browser doesn't support javascript.
loading
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.
Pinjusic, Katarina; Dubey, Olivier Andreas; Egorova, Olga; Nassiri, Sina; Meylan, Etienne; Faget, Julien; Constam, Daniel Beat.
Afiliación
  • Pinjusic K; School of Life Sciences (SV), ISREC, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Dubey OA; School of Life Sciences (SV), ISREC, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Egorova O; School of Life Sciences (SV), ISREC, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Nassiri S; Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Meylan E; School of Life Sciences (SV), ISREC, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Faget J; Laboratory of Immuno-Oncology, Bordet Cancer Research Laboratories, Institut Jules Bordet, Faculty of Medicine, and Laboratory of Immunobiology, Faculty of Sciences, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Constam DB; School of Life Sciences (SV), ISREC, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
J Immunother Cancer ; 10(5)2022 05.
Article en En | MEDLINE | ID: mdl-35580932

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activinas / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activinas / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Suiza